Mesoblast (MESO) Reports Q1 Loss of $0.04/Share

Mesoblast (NASDAQ: MESO) reported Q1 EPS of ($0.04), versus ($0.05) reported last year. Revenue for the quarter came in at $7.5 million, versus $7 million reported last year.

For earnings history and earnings-related data on Mesoblast (MESO) click here.

You May Also Be Interested In

• Is Treasury selloff a major issue for stock market bulls?
• BofA Securities Reiterates Buy Rating on Micron Technology (MU); Sees $230+ in EPS by FY30
• Jasper Therapeutics (JSPR) Tops Q2 EPS by 18c